The New Nasal Adrenaline

The New Nasal Adrenaline

I was absolutely thrilled to hear the news about the approval of the nasal adrenaline spray in the UK. This is a breakthrough that will transform how we respond to severe allergic reactions. For years, the only option for treating anaphylaxis has been the adrenaline auto-injector—a life-saving device, but one that comes with its own challenges. The pressure of having to stab yourself or someone else in a high-stress emergency is daunting, and for many, it’s a real barrier to timely treatment.

Now, with the introduction of EURneffy®, the first needle-free nasal spray for adrenaline, that pressure is lifted.

A simple spray into the nostril delivers the same life-saving medication quickly and effectively. This innovation is approved for adults and children weighing 30kg or more and is expected to be available by the end of 2025. It’s a huge step forward in making allergy management safer and less intimidating.

Why This Matters: Understanding Anaphylaxis

Anaphylaxis is a severe, life-threatening allergic reaction that can develop rapidly. It can be triggered by foods, insect stings, medications, or latex. Symptoms often include:

1. Swelling of the lips, tongue, or throat
2. Difficulty breathing or swallowing
3. Rapid heartbeat
4. Feeling faint or collapsing

If untreated, anaphylaxis can lead to cardiac arrest within minutes. That’s why adrenaline is the first-line treatment—it works by relaxing airway muscles, reducing swelling, and improving blood pressure.

According to our online book, the key steps in an anaphylaxis emergency are:

1. Call 999 immediately and state “anaphylaxis.”
2. Administer adrenaline without delay—traditionally via an auto-injector into the upper outer thigh.
3. Position the casualty lying down with legs raised (unless breathing is easier sitting up).
4. Give a second dose after 5 minutes if symptoms persist.
5. Monitor breathing and prepare for CPR if necessary.

How Nasal Adrenaline Changes the Game

The nasal spray removes the fear and hesitation associated with needles. It’s:

1. Needle-free – no stabbing, no fear.
2. Fast-acting – works even if the nose is blocked.
3. Simple to use – one quick spray instead of a stressful injection.

This means quicker treatment when every second counts and less anxiety for patients, parents, and caregivers. It also reduces the risk of incorrect technique, which is a common issue with auto-injectors.

Looking Ahead

This isn’t just a new product—it’s a revolution in allergy care. For those living with severe allergies, and for those of us who train others in first aid, this is a welcome development. It takes away the fear factor and gives people confidence that they can act fast without hesitation.

I, for one, couldn’t be happier to see this progress. It’s a big win for safety, simplicity, and peace of mind.